3-氯-4-萘-2-氧基苯胺 | 71311-87-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-氯-4-萘-2-氧基苯胺
• 英文名称: 3-chloro-4-(naphthalen-2-yloxy)aniline
• 英文别名: 3-Chloro-4-(2-naphthyloxy)aniline；3-chloro-4-naphthalen-2-yloxyaniline
• CAS: 71311-87-0
• 化学式: C₁₆H₁₂ClNO
• mdl: MFCD00437172
• 分子量: 269.73
• InChiKey: PHDLWURXDMFZON-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-氯-4-萘-2-氧基苯胺 在 potassium carbonate 作用下， 以 二氯甲烷 、 丙酮 为溶剂， 反应 1.5h， 生成 3,5-dichloro-N-(3-chloro-4-(naphthalen-2-yloxy)phenyl)-2-hydroxy-N-methylbenzamide
  参考文献：
  名称：

  Discovery and Structure–Activity Relationships of Modified Salicylanilides as Cell Permeable Inhibitors of Poly(ADP-ribose) Glycohydrolase (PARG)

  摘要：

  The metabolism of poly(ADP-ribose) (PAR) in response to DNA strand breaks, which involves the concerted activities of poly(ADP-ribose) polymerases (PARPs) and poly(ADP-ribose) glycohydrolase (PARG), modulates cell recovery or cell death depending upon the level of DNA damage. While PARP inhibitors show high promise in clinical trials because of their low toxicity and selectivity for BRCA related cancers, evaluation of the therapeutic potential of PARG is limited by the lack of well-validated cell permeable inhibitors. In this study, target-related affinity profiling (TRAP), an alternative to high-throughput screening, was used to identify a number of druglike compounds from several chemical classes that demonstrated PARG inhibition in the low-micromolar range. A number of analogues of one of the most active chemotypes were synthesized to explore the structure activity relationship (SAR) for that series. This led to the discovery of a putative pharmacophore for PARG inhibition that contains a modified salicylanilide structure. Interestingly, these compounds also inhibit PARP-1, indicating strong homology in the active sites of PARG and PARP-1 and raising a new challenge for development of PARG specific inhibitors. The cellular activity of a lead inhibitor was demonstrated by the inhibition of both PARP and PARG activity in squamous cell carcinoma cells, although preferential inhibition of PARG relative to PARP was observed. The ability of inhibitors to modulate PAR metabolism via simultaneous effects on PARPs and PARG may represent a new approach for therapeutic development.

  DOI：

  10.1021/jm200325s
• 作为产物：
  描述：

  3,4-二氯硝基苯 在 tin(II) chloride dihdyrate 、 caesium carbonate 作用下， 以 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 生成 3-氯-4-萘-2-氧基苯胺
  参考文献：
  名称：

  Discovery of INT131: A selective PPARγ modulator that enhances insulin sensitivity

  摘要：

  PPAR gamma is a member of the nuclear hormone receptor family and plays a key role in the regulation of glucose homeostasis. This Letter describes the discovery of a novel chemical class of diarylsulfonamide partial agonists that act as selective PPAR gamma modulators (SPPAR gamma Ms) and display a unique pharmacological profile compared to the thiazolidinedione (TZD) class of PPAR gamma full agonists. Herein we report the initial discovery of partial agonist 4 and the structure-activity relationship studies that led to the selection of clinical compound INT131 (3), a potent PPAR gamma partial agonist that displays robust glucose-lowering activity in rodent models of diabetes while exhibiting a reduced side-effects profile compared to marketed TZDs. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.11.058

文献信息

• N-(4-(2-chloro-4-(trifluoromethyl)phenoxy)phenyl)picolinamide as a new inhibitor of mitochondrial complex III: Synthesis, biological evaluation and computational simulations
  作者：Hua Cheng、Lu Yang、Hong-Fu Liu、Rui Zhang、Cheng Chen、Yuan Wu、Wen Jiang

  DOI：10.1016/j.bmcl.2020.127302

  日期：2020.8

  of pharmaceuticals and fungicides. Due to the wide-spread use of complex III-inhibiting fungicides, a considerable increase of resistance has occurred worldwide. Therefore, inhibitors with novel scaffolds and potent activity against complex III are still in great demand. In this article, a new series of amide compounds bearing the diaryl ether scaffold were designed and prepared, followed by the biological

  线粒体复合物III是许多药物和杀真菌剂最有希望的目标之一。由于复杂的抑制III族复合杀真菌剂的广泛使用，在世界范围内已经产生了很大的耐药性。因此，仍然强烈需要具有新颖支架和对复合物III有效活性的抑制剂。在本文中，设计并制备了一系列带有二芳基醚支架的酰胺化合物，然后进行了生物学评估。令人欣喜的是，几种化合物对琥珀酸-细胞色素c还原酶（SCR，线粒体复合物II和复合物III的混合物）表现出有效的活性，而化合物3w具有最佳的抑制活性（IC 50 = 0.91±0.09μmol/ L）。其他研究证实3w是复合物III的新抑制剂。此外，计算模拟表明3w应与复合物III的Q o位结合。我们相信这项工作对于制备和发现更复杂的III抑制剂将是有价值的。
• N-(3,5-Dichloro-4-(2,4,6-trichlorophenoxy)phenyl)benzenesulfonamide: A new dual-target inhibitor of mitochondrial complex II and complex III via structural simplification
  作者：Hua Cheng、Hong-Fu Liu、Lu Yang、Rui Zhang、Cheng Chen、Yuan Wu、Wen Jiang

  DOI：10.1016/j.bmc.2019.115299

  日期：2020.3

  Mitochondrial complex II and complex III are two promising targets for the development of numerous pharmaceuticals and pesticides. Although tremendous inhibitors of either complex II or complex III were identified, compounds which are capable of prohibiting the activities of both complexes have been rarely reported. Since multi-target drugs can interact with several drug targets simultaneously, we

  线粒体复合物II和复合物III是开发许多药物和农药的两个有希望的目标。尽管鉴定了复合物II或复合物III的巨大抑制剂，但很少报道能够抑制两种复合物活性的化合物。由于多靶标药物可以同时与多个药物靶标相互作用，因此我们渴望发现复合物II和复合物III的新型有效双靶标抑制剂。因此，本文设计并合成了一系列带有二芳基醚支架的结构简化的磺酰胺。之后，评估了新合成的化合物的生物活性。结果表明，几种化合物对琥珀酸-细胞色素c还原酶（SCR，配合物II和配合物III的混合物）。进一步的研究证实，本文中的代表性化合物N-（3,5-二氯-4-（2,4,6-三氯苯氧基）苯基）苯磺酰胺（3f）被鉴定为两种复合物的双重靶标抑制剂。此外，还进行了计算机模拟，以更好地了解3f与酶复合物的结合，得出的结论是3f应与复合物II和复合物III的Qo位点结合。因此，我们怀有这样的想法：这项工作对于合成和发现更多的双靶标或多靶标抑
• Discovery of 1,2,4-triazole-1,3-disulfonamides as dual inhibitors of mitochondrial complex II and complex III
  作者：Hua Cheng、Yan-Qing Shen、Xia-Yan Pan、Yi-Ping Hou、Qiong-You Wu、Guang-Fu Yang

  DOI：10.1039/c5nj00215j

  日期：——

  1,2,4-Triazole-1,3-disulfonamide derivatives as dual function inhibitors of mitochondrial complex II (SQR) and complex III (cytbc₁) were discovered.

  1,2,4-三唑-1,3-二磺酰胺衍生物被发现具有线粒体复合物II（SQR）和复合物III（细胞色素bc1）的双功能抑制剂作用。
• Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2
  作者：Qiufeng Liu、Fubao Huang、Xiaojing Yuan、Kai Wang、Yi Zou、Jianhua Shen、Yechun Xu

  DOI：10.1021/acs.jmedchem.7b01530

  日期：2017.12.28

  inhibitors derived from a relatively weak fragment. Similarity searching on this fragment followed by molecular docking leads to the discovery of a micromolar inhibitor with a 300-fold potency improvement. Subsequently, by the application of a structure-guided design strategy, a successful hit-to-lead optimization was achieved and a number of Lp-PLA2 inhibitors with single-digit nanomolar potency were obtained

  脂蛋白相关的磷脂酶A2（Lp-PLA2）是动脉粥样硬化，阿尔茨海默氏病和糖尿病性黄斑水肿的有希望的治疗靶标。在这里，我们报告鉴定衍生自相对较弱的片段的新型磺酰胺支架Lp-PLA2抑制剂。在该片段上进行相似搜索，然后进行分子对接，导致发现了一种微摩尔抑制剂，其效价提高了300倍。随后，通过应用结构指导的设计策略，成功实现了从头至尾的优化，并获得了许多具有单位数纳摩尔效价的Lp-PLA2抑制剂。在初步评估了体内和体外的药物相似性后，将化合物37该同类抑制剂系列在雄性Sprague-Dawley大鼠中具有良好的抑制活性和良好的口服生物利用度，从而脱颖而出，为进一步开发提供了良好的候选者。因此，本研究清楚地证明了在有效的铅发现项目中整合使用片段筛选，晶体结构确定，虚拟筛选和药物化学的功能和优势，为基于结构的药物设计提供了一个很好的例子。
• Herbicidal N-phenyl-N-methylurea derivatives
  申请人：Sumitomo Chemical Company, Limited

  公开号：US04280835A1

  公开（公告）日：1981-07-28

  Novel N'-4-(2-naphthyloxy)phenyl-N-methylurea derivatives of the formula: ##STR1## wherein X is a hydrogen atom, a halogen atom or a trifluoromethyl group and R is a methyl or methoxy group having a herbicidal activity, particularly effective in exterminating weeds in the cultivation of soybean and gramineous crops such as wheat and barley, and/or having a fungicidal activity especially effective in controlling the rust of wheat and barley.

  这是一种化合物，化学式为：##STR1## 其中X为氢原子、卤素原子或三氟甲基基团，R为甲基或甲氧基基团，具有除草活性，特别是在大豆和小麦、大麦等禾本科作物的栽培中，具有高效的除草作用，并且具有杀菌活性，特别是在控制小麦和大麦锈病方面具有高效的作用。